Novel Therapy for Acquired Tracheomalacia with a Tissue-Engineered Extraluminal Tracheal Splint and Autologous Mesenchymal-Derived Chondrocytes

Introduction  Acquired tracheomalacia (ATM) is characterized by a loss of structural strength of the tracheal framework, resulting in airway collapse during breathing. Near half of the patients undergoing prolonged invasive mechanical ventilation will suffer tracheal lesions. Treatment for ATM inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Melgarejo-Ramírez, Yaaziel, Ceballos-Cantú, Juan C., Montes-Olave, Eric de J., Hernández-Tapia, Bruno, Rojas-Figueroa, Víctor, Ramírez-Arroyo, Gabriela, Cortés-Acosta, Fabiana, Dorantes-Pavón, Mario, Lecona-Butrón, Hugo, Beltrán-Rodríguez-Cabo, Olga E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147475/
https://www.ncbi.nlm.nih.gov/pubmed/37125371
http://dx.doi.org/10.1055/s-0042-1746194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147475/
https://www.ncbi.nlm.nih.gov/pubmed/37125371
http://dx.doi.org/10.1055/s-0042-1746194

Ejemplares similares